Work

Swab-based molecular testing near the point-of-care for childhood tuberculosis: a prospective diagnostic accuracy study

Year: 2026
Type: preprint
Study design: Observational Study
Abstract: SUMMARY Background Swab-based molecular testing for tuberculosis (TB) could provide a near point-of-care (nPOC) diagnostic for children. We evaluated the accuracy of two swab-based nPOC platforms to detect pediatric pulmonary TB. Methods We prospectively enrolled children under 15 years with presumptive TB in Uganda and South Africa. They completed TB evaluation including sputum molecular testing and culture. Two tongue swabs were collected and tested with MiniDock MTB (Pluslife Biotech, China) and Truenat MTB Ultima (Molbio Diagnostics, India), and one swab was dipped in sputum for testing with MiniDock MTB. We calculated the sensitivity and specificity of each index test against a culture-based standard and compared them with sputum molecular testing and smear microscopy. Findings We included 335 children, among whom median age was 3 years (IQR 1-6), 53% were female, 11% were living with HIV, and 16% had microbiologically confirmed TB. Tongue swabs were collected in all children, with invalid test rates of less than 3%. Against a culture-based standard, the sensitivities of tongue swab MiniDock MTB and MTB Ultima were 50% (95% CI 33.4-66.6) and 50% (95% CI 28.2-71.8), respectively, and specificities were ≥98% for both. Sputum swab MiniDock MTB had similar sensitivity to sputum Xpert Ultra (85.7% vs. 75.0%, p=0.45), but substantially higher sensitivity than tongue swab MiniDock MTB (+23.1%, p=0.03) and sputum smear microscopy (+46.4%, p<0.001). Interpretation Sputum swab testing had similar accuracy to sputum Xpert Ultra in children. Tongue swab testing had moderate accuracy, and has value to identify microbiologically confirmed cases when sputum is not available. Funding National Institutes of Health, United States Department of State Bureau of Global Health Security and Diplomacy, and South African Medical Research Council RESEARCH IN CONTEXT Evidence before this study We evaluated the literature from October 2021 to October 2026 for studies in any language on oral swab molecular testing for M. tuberculosis (MTB). We included diagnostic accuracy studies and excluded work on extrapulmonary TB, screening and early assay development, and searched PubMed and Google Scholar with the terms “swab” AND “tuberculosis” AND “diagnosis.” Manual quantitative polymerase chain reaction (qPCR) testing on tongue swabs has high accuracy to detect pulmonary TB in adults (80-93% sensitive and >98% specificity), with similar accuracy to sputum samples. Translation to semi-automated PCR assays such as Xpert Ultra have had high specificity but variable sensitivity (59-76%). Newer assays have been developed that are designed specifically for swab testing, and are small, portable, and can be used near the point-of-care (nPOC). Studies in adults have found that nPOC tongue swab testing is feasible, sensitive (75-86%), and specific (>96%). Testing can also be performed by dipping a swab in sputum, offering higher accuracy than tongue swabs and similar performance to sputum Xpert Ultra. However, the evidence in children has been limited to Xpert Ultra tongue swab testing, with low sensitivity (7-19%). Added value of this study To our knowledge, this is the first assessment of two swab-based nPOC assays for childhood TB: MiniDock MTB and MTB Ultima. In two high TB-burden settings of South Africa and Uganda, we prospectively enrolled children with presumptive TB and determined the accuracy of tongue and sputum swab testing. We found that tongue swab testing detected about half of children with culture-confirmed TB; sputum swab testing had substantially higher sensitivity than tongue swabs, and similar performance to sputum Xpert Ultra, meeting the World Health Organization (WHO) target accuracy for an nPOC sputum molecular TB test. Implications of all the available evidence The recent WHO guidelines endorsed sputum swab testing in adults and adolescents, and tongue swabs if sputum is not available. Similarly, we found that a single platform can enable nPOC molecular testing for TB among children, with sputum swab accuracy comparable to Xpert Ultra when sputum is available, and tongue swabs providing a simple, non-invasive approach to increase microbiological confirmation and potentially reduce delays in treatment when sputum is not available.
Source: medRxiv
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W7236216159
Cites: 20
Cited by:
Related to: 10